Steven Hill
Algemeen Directeur bij NEWHYDROGEN, INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Steven Hill
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NEWHYDROGEN, INC. | Directeur/Bestuurslid | 20-03-2023 | - |
Algemeen Directeur | 15-06-2023 | - | |
Corporate Officer/Principal | 20-03-2023 | 15-06-2023 |
Loopbaan van Steven Hill
Eerdere bekende functies van Steven Hill
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Hill Investments LLC | Corporate Officer/Principal | 01-10-2016 | 01-02-2023 |
RELYPSA INC | Comptroller/Controller/Auditor | 01-12-2015 | 01-10-2021 |
Opleiding van Steven Hill
Instituto de Empresa SL | Masters Business Admin |
Utah Valley University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
2 | |
Spanje | 2 |
Operationeel
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
NewHydrogen, Inc. | |
Relypsa, Inc.
Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Hill Investments LLC |
- Beurs
- Insiders
- Steven Hill
- Ervaring